Global Wilson's Disease 麻豆原创 2024 by Company, Regions, Type and Application, Forecast to 2030

Publication ID:

GIR092413596

Publication Date:

September 20, 2024

Pages:

103

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Wilson鈥檚 disease is also known as progressive lenticular degeneration and hepatolenticular degeneration that causes copper poisoning in the body. Copper is a necessary element for cellular functions; however, excessive copper is extremely toxic and can cause permanent damage to cellular functions of body. Wilson鈥檚 disease is caused by excessive deposition of copper in the body. Generally, copper is released into bile from the diet is cleaned out by the liver, flowing out of the body from the gastrointestinal tract. Wilson鈥檚 disease occurs due to excessive deposition of copper in the brain, liver, and other tissues of the body. According to the American Association for the Study of Liver Diseases, Wilson鈥檚 disease occurs worldwide with prevalence of approximately 30 individuals affected per million.
The global Wilson's Disease market size was valued at US$ 220 million in 2023 and is forecast to a readjusted size of USD 290 million by 2030 with a CAGR of 4.1% during review period.
The classification of Wilson鈥檚 disease includes Trientine, Penicillamine and others, and the proportion of Trientine in 2019 is about 47%. Penicillamine was the first drug approved for the treatment of Wilson鈥檚 disease. Penicillamine is the most successful drug used for the treatment of Wilson鈥檚 disease. Wilson鈥檚 disease is widely used in Hospital, drugs stores and other field. The most proportion of Wilson鈥檚 disease is Drugs听Store, and the proportion in 2019 is 51%. North America is the largest consumption place, with a consumption market share nearly 76.93% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of 10.51%. 麻豆原创 competition is intense. Bausch Health, Teva, Endo International, Univar Solutions, MSN Laboratories, etc. are the leaders of the industry.
This report is a detailed and comprehensive analysis for global Wilson's Disease market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Wilson's Disease market size and forecasts, in consumption value ($ Million), 2019-2030
Global Wilson's Disease market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Wilson's Disease market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global Wilson's Disease market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Wilson's Disease
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Wilson's Disease market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bausch Health, Teva, Endo International, Univar Solutions, MSN Laboratories, ANI Pharmaceuticals, APOTEX, Tsumura, Sinepharm, Taj Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 segmentation
Wilson's Disease market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segmentation
Wilson's Disease market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Trientine
Penicillamine
Others
麻豆原创 segment by Application
Hospital
Drugs Stores
Others
麻豆原创 segment by players, this report covers
Bausch Health
Teva
Endo International
Univar Solutions
MSN Laboratories
ANI Pharmaceuticals
APOTEX
Tsumura
Sinepharm
Taj Pharmaceutical
Kadmon Holdings
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Wilson's Disease product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Wilson's Disease, with revenue, gross margin, and global market share of Wilson's Disease from 2019 to 2024.
Chapter 3, the Wilson's Disease competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Wilson's Disease market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Wilson's Disease.
Chapter 13, to describe Wilson's Disease research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Wilson's Disease by Type
1.3.1 Overview: Global Wilson's Disease 麻豆原创 Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Wilson's Disease Consumption Value 麻豆原创 Share by Type in 2023
1.3.3 Trientine
1.3.4 Penicillamine
1.3.5 Others
1.4 Global Wilson's Disease 麻豆原创 by Application
1.4.1 Overview: Global Wilson's Disease 麻豆原创 Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Drugs Stores
1.4.4 Others
1.5 Global Wilson's Disease 麻豆原创 Size & Forecast
1.6 Global Wilson's Disease 麻豆原创 Size and Forecast by Region
1.6.1 Global Wilson's Disease 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Wilson's Disease 麻豆原创 Size by Region, (2019-2030)
1.6.3 North America Wilson's Disease 麻豆原创 Size and Prospect (2019-2030)
1.6.4 Europe Wilson's Disease 麻豆原创 Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Wilson's Disease 麻豆原创 Size and Prospect (2019-2030)
1.6.6 South America Wilson's Disease 麻豆原创 Size and Prospect (2019-2030)
1.6.7 Middle East & Africa Wilson's Disease 麻豆原创 Size and Prospect (2019-2030)
2 Company Profiles
2.1 Bausch Health
2.1.1 Bausch Health Details
2.1.2 Bausch Health Major Business
2.1.3 Bausch Health Wilson's Disease Product and Solutions
2.1.4 Bausch Health Wilson's Disease Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 Bausch Health Recent Developments and Future Plans
2.2 Teva
2.2.1 Teva Details
2.2.2 Teva Major Business
2.2.3 Teva Wilson's Disease Product and Solutions
2.2.4 Teva Wilson's Disease Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 Teva Recent Developments and Future Plans
2.3 Endo International
2.3.1 Endo International Details
2.3.2 Endo International Major Business
2.3.3 Endo International Wilson's Disease Product and Solutions
2.3.4 Endo International Wilson's Disease Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 Endo International Recent Developments and Future Plans
2.4 Univar Solutions
2.4.1 Univar Solutions Details
2.4.2 Univar Solutions Major Business
2.4.3 Univar Solutions Wilson's Disease Product and Solutions
2.4.4 Univar Solutions Wilson's Disease Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 Univar Solutions Recent Developments and Future Plans
2.5 MSN Laboratories
2.5.1 MSN Laboratories Details
2.5.2 MSN Laboratories Major Business
2.5.3 MSN Laboratories Wilson's Disease Product and Solutions
2.5.4 MSN Laboratories Wilson's Disease Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 MSN Laboratories Recent Developments and Future Plans
2.6 ANI Pharmaceuticals
2.6.1 ANI Pharmaceuticals Details
2.6.2 ANI Pharmaceuticals Major Business
2.6.3 ANI Pharmaceuticals Wilson's Disease Product and Solutions
2.6.4 ANI Pharmaceuticals Wilson's Disease Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 ANI Pharmaceuticals Recent Developments and Future Plans
2.7 APOTEX
2.7.1 APOTEX Details
2.7.2 APOTEX Major Business
2.7.3 APOTEX Wilson's Disease Product and Solutions
2.7.4 APOTEX Wilson's Disease Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.7.5 APOTEX Recent Developments and Future Plans
2.8 Tsumura
2.8.1 Tsumura Details
2.8.2 Tsumura Major Business
2.8.3 Tsumura Wilson's Disease Product and Solutions
2.8.4 Tsumura Wilson's Disease Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.8.5 Tsumura Recent Developments and Future Plans
2.9 Sinepharm
2.9.1 Sinepharm Details
2.9.2 Sinepharm Major Business
2.9.3 Sinepharm Wilson's Disease Product and Solutions
2.9.4 Sinepharm Wilson's Disease Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.9.5 Sinepharm Recent Developments and Future Plans
2.10 Taj Pharmaceutical
2.10.1 Taj Pharmaceutical Details
2.10.2 Taj Pharmaceutical Major Business
2.10.3 Taj Pharmaceutical Wilson's Disease Product and Solutions
2.10.4 Taj Pharmaceutical Wilson's Disease Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.10.5 Taj Pharmaceutical Recent Developments and Future Plans
2.11 Kadmon Holdings
2.11.1 Kadmon Holdings Details
2.11.2 Kadmon Holdings Major Business
2.11.3 Kadmon Holdings Wilson's Disease Product and Solutions
2.11.4 Kadmon Holdings Wilson's Disease Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.11.5 Kadmon Holdings Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Wilson's Disease Revenue and Share by Players (2019-2024)
3.2 麻豆原创 Share Analysis (2023)
3.2.1 麻豆原创 Share of Wilson's Disease by Company Revenue
3.2.2 Top 3 Wilson's Disease Players 麻豆原创 Share in 2023
3.2.3 Top 6 Wilson's Disease Players 麻豆原创 Share in 2023
3.3 Wilson's Disease 麻豆原创: Overall Company Footprint Analysis
3.3.1 Wilson's Disease 麻豆原创: Region Footprint
3.3.2 Wilson's Disease 麻豆原创: Company Product Type Footprint
3.3.3 Wilson's Disease 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Wilson's Disease Consumption Value and 麻豆原创 Share by Type (2019-2024)
4.2 Global Wilson's Disease 麻豆原创 Forecast by Type (2025-2030)
5 麻豆原创 Size Segment by Application
5.1 Global Wilson's Disease Consumption Value 麻豆原创 Share by Application (2019-2024)
5.2 Global Wilson's Disease 麻豆原创 Forecast by Application (2025-2030)
6 North America
6.1 North America Wilson's Disease Consumption Value by Type (2019-2030)
6.2 North America Wilson's Disease 麻豆原创 Size by Application (2019-2030)
6.3 North America Wilson's Disease 麻豆原创 Size by Country
6.3.1 North America Wilson's Disease Consumption Value by Country (2019-2030)
6.3.2 United States Wilson's Disease 麻豆原创 Size and Forecast (2019-2030)
6.3.3 Canada Wilson's Disease 麻豆原创 Size and Forecast (2019-2030)
6.3.4 Mexico Wilson's Disease 麻豆原创 Size and Forecast (2019-2030)
7 Europe
7.1 Europe Wilson's Disease Consumption Value by Type (2019-2030)
7.2 Europe Wilson's Disease Consumption Value by Application (2019-2030)
7.3 Europe Wilson's Disease 麻豆原创 Size by Country
7.3.1 Europe Wilson's Disease Consumption Value by Country (2019-2030)
7.3.2 Germany Wilson's Disease 麻豆原创 Size and Forecast (2019-2030)
7.3.3 France Wilson's Disease 麻豆原创 Size and Forecast (2019-2030)
7.3.4 United Kingdom Wilson's Disease 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Russia Wilson's Disease 麻豆原创 Size and Forecast (2019-2030)
7.3.6 Italy Wilson's Disease 麻豆原创 Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Wilson's Disease Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Wilson's Disease Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Wilson's Disease 麻豆原创 Size by Region
8.3.1 Asia-Pacific Wilson's Disease Consumption Value by Region (2019-2030)
8.3.2 China Wilson's Disease 麻豆原创 Size and Forecast (2019-2030)
8.3.3 Japan Wilson's Disease 麻豆原创 Size and Forecast (2019-2030)
8.3.4 South Korea Wilson's Disease 麻豆原创 Size and Forecast (2019-2030)
8.3.5 India Wilson's Disease 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Southeast Asia Wilson's Disease 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Australia Wilson's Disease 麻豆原创 Size and Forecast (2019-2030)
9 South America
9.1 South America Wilson's Disease Consumption Value by Type (2019-2030)
9.2 South America Wilson's Disease Consumption Value by Application (2019-2030)
9.3 South America Wilson's Disease 麻豆原创 Size by Country
9.3.1 South America Wilson's Disease Consumption Value by Country (2019-2030)
9.3.2 Brazil Wilson's Disease 麻豆原创 Size and Forecast (2019-2030)
9.3.3 Argentina Wilson's Disease 麻豆原创 Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Wilson's Disease Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Wilson's Disease Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Wilson's Disease 麻豆原创 Size by Country
10.3.1 Middle East & Africa Wilson's Disease Consumption Value by Country (2019-2030)
10.3.2 Turkey Wilson's Disease 麻豆原创 Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Wilson's Disease 麻豆原创 Size and Forecast (2019-2030)
10.3.4 UAE Wilson's Disease 麻豆原创 Size and Forecast (2019-2030)
11 麻豆原创 Dynamics
11.1 Wilson's Disease 麻豆原创 Drivers
11.2 Wilson's Disease 麻豆原创 Restraints
11.3 Wilson's Disease Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Wilson's Disease Industry Chain
12.2 Wilson's Disease Upstream Analysis
12.3 Wilson's Disease Midstream Analysis
12.4 Wilson's Disease Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.